GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Revvity RVTY · USD

Health Care · Life Sciences Tools & Services · US listing · 🇺🇸 United States

S&P 500

Compare

160.72

+3.62%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

25 analysts, 1 Nov 2026. The analysts' own views, not ours.

  • 5Strong buy
  • 6Buy
  • 14Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Nov 2026. Not our view.

Average target 110.40

Low
95.00
Average
110.40
Median
115.00
High
125.00

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
Revenue$2.85bn$3.01bn$3.18bn$3.40bn$3.58bn
Revenue, highest$2.92bn$3.02bn$3.24bn$3.43bn$3.62bn
Revenue, lowest$2.83bn$2.99bn$3.13bn$3.37bn$3.55bn
Earnings per share5.365.906.467.087.72
Earnings per share, highest5.405.929.807.187.84
Earnings per share, lowest5.355.874.737.007.64
Analysts12121077

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Forecast1.301.211.041.581.161.160.971.40
Reported1.381.411.061.701.181.181.011.42
Difference+6.2%+16.5%+2.3%+7.4%+1.7%+1.5%+4.3%+1.6%

Rating changes

Latest broker notes

  • Evercore ISI GroupOutperform
  • Evercore ISI GroupOutperform
  • BarclaysEqual Weight
  • TD CowenBuy
  • StifelHold
  • JP MorganNeutral
  • BairdOutperform
  • Goldman SachsNeutral
  • BarclaysOverweight → Equal Weight
  • JP MorganNeutral
  • Wells FargoEqual Weight
  • TD CowenBuy

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

0 / 10

Revenue growth 3.1% a year over 10 years. Return on equity 3.3%.

Model fair value

190.12

From earnings 190.12, from revenue 112.34.

Piotroski score

3 / 9

A nine-point test of financial strength, for 28 Dec 2025.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.